ESSA Pharma Inc.

ESSA Pharma Inc.

Biotechnology Healthcare Vancouver, BC, United States EPIX (NCM)

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company was incorporated in 2009 and is headquartered in Vancouver, Canada. As of October 9, 2025, ESSA Pharma Inc. operates as a subsidiary of Alexis Bio, Inc.

Stock Performance

Stock price data not yet populated

Symbol: EPIX

Layoff History

No layoff events recorded for this company.

Recent News

Other Biotechnology Companies

View All →

Frequently Asked Questions

Has ESSA Pharma Inc. had layoffs?
No layoff events have been recorded for ESSA Pharma Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does ESSA Pharma Inc. have?
ESSA Pharma Inc. has approximately 35 employees.
What industry is ESSA Pharma Inc. in?
ESSA Pharma Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is ESSA Pharma Inc. a publicly traded company?
Yes, ESSA Pharma Inc. is publicly traded under the ticker symbol EPIX on the NCM. The company has a market capitalization of approximately $0.01 billion.
Where is ESSA Pharma Inc. headquartered?
ESSA Pharma Inc. is headquartered in Vancouver, BC, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.